| Identification | Back Directory | [Name]
L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-, 2,2,2-trifluoroacetate (1:1) | [CAS]
1606994-55-1 | [Synonyms]
RX-31 TFA
SS-31 TFA)
MTP-131 (TFA)
Elamipretide TFA
Elamipretide TFA (MTP-131 TFA
ELAMIPRETIDE TFA (MTP-131 TFA; RX-31 TFA; SS-31 TFA)
L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-, 2,2,2-trifluoroacetate (1:1) | [Molecular Formula]
C34H50F3N9O7 | [MDL Number]
MFCD31746869 | [MOL File]
1606994-55-1.mol | [Molecular Weight]
753.83 |
| Hazard Information | Back Directory | [Description]
Elamipretide TFA (MTP-131 TFA; RX-31 TFA; SS-31 TFA) is a cardiolipin peroxidase inhibitor and mitochondria-targeting peptide[1]. Cardiolipin peroxidase[1] | [References]
[1]. Sabbah HN et al. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure. Circ Heart Fail. 2016 Feb;9(2):e002206. |
|
|